Zevra Therapeutics (ZVRA) Net Cash Flow (QoQ) (2014 - 2026)
Zevra Therapeutics (ZVRA) Net Cash Flow (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 297.59% |
| Dec 31, 2025 | 24.40% |
| Sep 30, 2025 | -31.41% |
| Jun 30, 2025 | 147.36% |
| Mar 31, 2025 | 118.77% |
| Dec 31, 2024 | -237.03% |
| Sep 30, 2024 | 490.74% |
| Jun 30, 2024 | -2,421.29% |
| Mar 31, 2024 | 72.76% |
| Dec 31, 2023 | 97.51% |
| Sep 30, 2023 | -186.84% |
| Jun 30, 2023 | 203.68% |
| Mar 31, 2023 | -422.68% |
| Dec 31, 2022 | 27.25% |
| Sep 30, 2022 | 71.55% |
| Jun 30, 2022 | -93.12% |
| Mar 31, 2022 | 36.66% |
| Dec 31, 2021 | -2,318.81% |
| Sep 30, 2021 | -101.41% |
| Jun 30, 2021 | -21.53% |